Sign in
Explore the registryTrack Zanubrutinib oral product's trials

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Zanubrutinib Oral ProductOngoingRecruitingPhase 2Open NCT06544785 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…